A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome.
Ray Mun KooEric WongJoanne E DavisTravis PereraAndrew LimRachel M KoldejDavid S RitchiePublished in: Bone marrow transplantation (2024)